Signal sequence insufficiency contributes to neurodegeneration caused by transmembrane prion protein

Journal of Cell Biology

Volumn 188, Issue 4, 2010, Pages 515-526

  Rane, Neena S ^a   Chakrabarti, Oishee ^a   Feigenbaum, Lionel ^b   Hegde, Ramanujan S ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAMMALIAN PRION PROTEIN; MEMBRANE PROTEIN; MUTANT PROTEIN; PRION PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENE MUTATION; IN VIVO STUDY; MOUSE; NERVE DEGENERATION; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; PROTEIN DOMAIN; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

ANIMALS; CELLS, CULTURED; CRICETINAE; HUMANS; HUNTINGTON DISEASE; MEMBRANE PROTEINS; MICE; MICE, TRANSGENIC; MUTATION; NERVE DEGENERATION; PHENOTYPE; PRIONS; PROTEIN SORTING SIGNALS; PROTEIN TRANSPORT;

MAMMALIAN PRION; MUS; MUS MUSCULUS;

EID: 77149179440     PISSN: 00219525     EISSN: 00219525     Source Type: Journal    
DOI: 10.1083/jcb.200911115     Document Type: Article

References (52)

1. Anandatheerthavarada, H.K., G. Biswas, M.A. Robin, and N.G. Avadhani. 2003. Mitochondrial targeting and a novel transmembrane arrest of Alzheimer's amyloid precursor protein impairs mitochondrial function in neuronal cells. J. Cell Biol. 161:41-54. doi:10.1083/jcb.200207030
2. Belin, D., S. Bost, J.D. Vassalli, and K. Strub. 1996. A two-step recognition of signal sequences determines the translocation efficiency of proteins. EMBO J. 15:468-478.
3. Besemer, J., H. Harant, S. Wang, B. Oberhauser, K. Marquardt, C.A. Foster, E.P. Schreiner, J.E. de Vries, C. Dascher-Nadel, and I.J. Lindley. 2005. Selective inhibition of cotranslational translocation of vascular cell adhesion molecule 1. Nature. 436:290-293. doi:10.1038/nature03670
4. Chakrabarti, O., and R.S. Hegde. 2009. Functional depletion of mahogunin by cytosolically exposed prion protein contributes to neurodegeneration. Cell. 137:1136-1147. doi:10.1016/j.cell.2009.03.042
5. Chakrabarti, O., A. Ashok, and R.S. Hegde. 2009. Prion protein biosynthesis and its emerging role in neurodegeneration. Trends Biochem. Sci. 34:287-295. doi:10.1016/j.tibs.2009.03.001
6. Chiesa, R., P. Piccardo, E. Biasini, B. Ghetti, and D.A. Harris. 2008. Aggregated, wild-type prion protein causes neurological dysfunction and synaptic abnormalities. J. Neurosci. 28:13258-13267. doi:10.1523/ JNEUROSCI.3109-08.2008
7. Chondrogianni, N., and E.S. Gonos. 2005. Proteasome dysfunction in mammalian aging: steps and factors involved. Exp. Gerontol. 40:931-938. doi:10.1016/j.exger.2005.09.004
8. Donne, D.G., J.H. Viles, D. Groth, I. Mehlhorn, T.L. James, F.E. Cohen, S.B. Prusiner, P.E. Wright, and H.J. Dyson. 1997. Structure of the recombinant full-length hamster prion protein PrP(29-231): the N terminus is highly flexible. Proc. Natl. Acad. Sci. USA. 94:13452-13457. doi:10.1073/pnas.94.25.13452
9. Drisaldi, B., R.S. Stewart, C. Adles, L.R. Stewart, E. Quaglio, E. Biasini, L. Fioriti, R. Chiesa, and D.A. Harris. 2003. Mutant PrP is delayed in its exit from the endoplasmic reticulum, but neither wild-type nor mutant PrP undergoes retrotranslocation prior to proteasomal degradation. J. Biol. Chem. 278:21732-21743. doi:10.1074/jbc.M213247200
10. Fons, R.D., B.A. Bogert, and R.S. Hegde. 2003. Substrate-specific function of the translocon-associated protein complex during translocation across the ER membrane. J. Cell Biol. 160:529-539. doi:10.1083/jcb. 200210095
11. Garrison, J.L., E.J. Kunkel, R.S. Hegde, and J. Taunton. 2005. A substrate-specific inhibitor of protein translocation into the endoplasmic reticulum. Nature. 436:285-289. doi:10.1038/nature03821
12. Hegde, R.S., and H.D. Bernstein. 2006. The surprising complexity of signal sequences. Trends Biochem. Sci. 31:563-571. doi:10.1016/j.tibs. 2006.08.004
13. Hegde, R.S., and S.W. Kang. 2008. The concept of translocational regulation. J. Cell Biol. 182:225-232. doi:10.1083/jcb.200804157
14. Hegde, R.S., J.A. Mastrianni, M.R. Scott, K.A. DeFea, P. Tremblay, M. Torchia, S.J. DeArmond, S.B. Prusiner, and V.R. Lingappa. 1998a. A transmembrane form of the prion protein in neurodegenerative disease. Science. 279:827-834. doi:10.1126/science.279.5352.827
15. Hegde, R.S., S. Voigt, and V.R. Lingappa. 1998b. Regulation of protein topology by trans-acting factors at the endoplasmic reticulum. Mol. Cell. 2:85-91. doi:10.1016/S1097-2765(00)80116-1
16. Hegde, R.S., P. Tremblay, D. Groth, S.J. DeArmond, S.B. Prusiner, and V.R. Lingappa. 1999. Transmissible and genetic prion diseases share a common pathway of neurodegeneration. Nature. 402:822-826. doi:10.1038/45574
17. Hsiao, K.K., C. Cass, G.D. Schellenberg, T. Bird, E. Devine-Gage, H. Wisniewski, and S.B. Prusiner. 1991. A prion protein variant in a family with the telencephalic form of Gerstmann-Sträussler-Scheinker syndrome. Neurology. 41:681-684.
18. Kang, S.W., N.S. Rane, S.J. Kim, J.L. Garrison, J. Taunton, and R.S. Hegde. 2006. Substrate-specific translocational attenuation during ER stress defines a pre-emptive quality control pathway. Cell. 127:999-1013. doi:10.1016/ j.cell.2006.10.032
19. Kim, S.J., and R.S. Hegde. 2002. Cotranslational partitioning of nascent prion protein into multiple populations at the translocation channel. Mol. Biol. Cell. 13:3775-3786. doi:10.1091/mbc.E02-05-0293
20. Kim, S.J., R. Rahbar, and R.S. Hegde. 2001. Combinatorial control of prion protein biogenesis by the signal sequence and transmembrane domain. J. Biol. Chem. 276:26132-26140. doi:10.1074/jbc.M101638200
21. Kim, S.J., D. Mitra, J.R. Salerno, and R.S. Hegde. 2002. Signal sequences control gating of the protein translocation channel in a substrate-specific manner. Dev. Cell. 2:207-217. doi:10.1016/S1534-5807(01)00120-4
22. Kristiansen, M., P. Deriziotis, D.E. Dimcheff, G.S. Jackson, H. Ovaa, H. Naumann, A.R. Clarke, F.W. van Leeuwen, V. Menéndez-Benito, N.P. Dantuma, et al. 2007. Disease-associated prion protein oligomers inhibit the 26S proteasome. Mol. Cell. 26:175-188. doi:10.1016/j.molcel.2007.04.001
23. Levine, C.G., D. Mitra, A. Sharma, C.L. Smith, and R.S. Hegde. 2005. The efficiency of protein compartmentalization into the secretory pathway. Mol. Biol. Cell. 16:279-291. doi:10.1091/mbc.E04-06-0508
24. Lopez, C.D., C.S. Yost, S.B. Prusiner, R.M. Myers, and V.R. Lingappa. 1990. Unusual topogenic sequence directs prion protein biogenesis. Science. 248:226-229. doi:10.1126/science.1970195
25. Ma, J., and S. Lindquist. 2001. Wild-type PrP and a mutant associated with prion disease are subject to retrograde transport and proteasome degradation. Proc. Natl. Acad. Sci. USA. 98:14955-14960. doi:10.1073/ pnas.011578098
26. Ma, J., R. Wollmann, and S. Lindquist. 2002. Neurotoxicity and neurodegeneration when PrP accumulates in the cytosol. Science. 298:1781-1785. doi:10.1126/science.1073725
27. Martoglio, B., and B. Dobberstein. 1998. Signal sequences: more than just greasy peptides. Trends Cell Biol. 8:410-415. doi:10.1016/S0962-8924(98) 01360-9
28. Orsi, A., L. Fioriti, R. Chiesa, and R. Sitia. 2006. Conditions of endoplasmic reticulum stress favor the accumulation of cytosolic prion protein. J. Biol. Chem. 281:30431-30438. doi:10.1074/jbc.M605320200
29. Panegyres, P.K., K. Toufexis, B.A. Kakulas, L. Cernevakova, P. Brown, B. Ghetti, P. Piccardo, and S.R. Dlouhy. 2001. A new PRNP mutation (G131V) associated with Gerstmann-Sträussler-Scheinker disease. Arch. Neurol. 58:1899-1902. doi:10.1001/archneur.58.11.1899
30. Peto, R., and J. Peto. 1972. Asymptotically efficient rank invariant test procedures. J. R. Stat. Soc. Ser. A Stat. Soc. 135:185-207.
31. Prusiner, S.B., M.R. Scott, S.J. DeArmond, and F.E. Cohen. 1998. Prion protein biology. Cell. 93:337-348. doi:10.1016/S0092-8674(00)81163-0
32. Rane, N.S., J.L. Yonkovich, and R.S. Hegde. 2004. Protection from cytosolic prion protein toxicity by modulation of protein translocation. EMBO J. 23:4550-4559. doi:10.1038/sj.emboj.7600462
33. Rane, N.S., S.W. Kang, O. Chakrabarti, L. Feigenbaum, and R.S. Hegde. 2008. Reduced translocation of nascent prion protein during ER stress contributes to neurodegeneration. Dev. Cell. 15:359-370. doi:10.1016/ j.devcel.2008.06.015
34. Rapoport, T.A. 2007. Protein translocation across the eukaryotic endoplasmic reticulum and bacterial plasma membranes. Nature. 450:663-669. doi:10.1038/nature06384
35. Riek, R., S. Hornemann, G. Wider, M. Billeter, R. Glockshuber, and K. Wüthrich. 1996. NMR structure of the mouse prion protein domain PrP(121-321). Nature. 382:180-182. doi:10.1038/382180a0
36. Riek, R., S. Hornemann, G. Wider, R. Glockshuber, and K. Wüthrich. 1997. NMR characterization of the full-length recombinant murine prion protein, mPrP(23-231). FEBS Lett. 413:282-288. doi:10.1016/S0014-5793(97)00920-4
37. Rodriguez, M.M., K. Peoc'h, S. Haïk, C. Bouchet, L. Vernengo, G. Mañana, R. Salamano, L. Carrasco, M. Lenne, P. Beaudry, et al. 2005. A novel mutation (G114V) in the prion protein gene in a family with inherited prion disease. Neurology. 64:1455-1457.
38. Rogers, M., D. Serban, T. Gyuris, M. Scott, T. Torchia, and S.B. Prusiner. 1991. Epitope mapping of the Syrian hamster prion protein utilizing chimeric and mutant genes in a vaccinia virus expression system. J. Immunol. 147:3568-3574.
39. Rutkowski, D.T., V.R. Lingappa, and R.S. Hegde. 2001. Substrate-specific regulation of the ribosome- translocon junction by N-terminal signal sequences. Proc. Natl. Acad. Sci. USA. 98:7823-7828. doi:10.1073/pnas.141125098
40. Rutkowski, D.T., S.W. Kang, A.G. Goodman, J.L. Garrison, J. Taunton, M.G. Katze, R.J. Kaufman, and R.S. Hegde. 2007. The role of p58IPK in protecting the stressed endoplasmic reticulum. Mol. Biol. Cell. 18:3681-3691. doi:10.1091/mbc.E07-03-0272
41. Scott, M., D. Foster, C. Mirenda, D. Serban, F. Coufal, M. Wälchli, M. Torchia, D. Groth, G. Carlson, S.J. DeArmond, et al. 1989. Transgenic mice expressing hamster prion protein produce species-specific scrapie infectivity and amyloid plaques. Cell. 59:847-857. doi:10.1016/0092-8674(89)90608-9
42. Shaffer, K.L., A. Sharma, E.L. Snapp, and R.S. Hegde. 2005. Regulation of protein compartmentalization expands the diversity of protein function. Dev. Cell. 9:545-554. doi:10.1016/j.devcel.2005.09.001
43. Stewart, R.S., and D.A. Harris. 2003. Mutational analysis of topological determinants in prion protein (PrP) and measurement of transmembrane and cytosolic PrP during prion infection. J. Biol. Chem. 278:45960-45968. doi:10.1074/jbc.M307833200
44. Stewart, R.S., and D.A. Harris. 2005. A transmembrane form of the prion protein is localized in the Golgi apparatus of neurons. J. Biol. Chem. 280:15855-15864. doi:10.1074/jbc.M412298200
45. Stewart, R.S., P. Piccardo, B. Ghetti, and D.A. Harris. 2005. Neurodegenerative illness in transgenic mice expressing a transmembrane form of the prion protein. J. Neurosci. 25:3469-3477. doi:10.1523/JNEUROSCI. 0105-05.2005
46. Tateishi, J., T. Kitamoto, K. Doh-ura, Y. Sakaki, G. Steinmetz, C. Tranchant, J.M. Warter, and N. Heldt. 1990. Immunochemical, molecular genetic, and transmission studies on a case of Gerstmann-Sträussler-Scheinker syndrome. Neurology. 40:1578-1581.
47. Tremblay, P., E. Bouzamondo-Bernstein, C. Heinrich, S.B. Prusiner, and S.J. DeArmond. 2007. Developmental expression of PrP in the post-implantation embryo. Brain Res. 1139:60-67. doi:10.1016/j.brainres.2006.12.055
48. Voigt, S., B. Jungnickel, E. Hartmann, and T.A. Rapoport. 1996. Signal sequence-dependent function of the TRAM protein during early phases of protein transport across the endoplasmic reticulum membrane. J. Cell Biol. 134:25-35. doi:10.1083/jcb.134.1.25
49. von Heijne, G. 1985. Signal sequences. The limits of variation. J. Mol. Biol. 184:99-105. doi:10.1016/0022-2836(85)90046-4
50. Westaway, D., S.J. DeArmond, J. Cayetano-Canlas, D. Groth, D. Foster, S.L. Yang, M. Torchia, G.A. Carlson, and S.B. Prusiner. 1994. Degeneration of skeletal muscle, peripheral nerves, and the central nervous system in transgenic mice overexpressing wild-type prion proteins. Cell. 76:117-129. doi:10.1016/0092-8674(94)90177-5
51. Yang, W., J. Cook, B. Rassbach, A. Lemus, S.J. DeArmond, and J.A. Mastrianni. 2009. A new transgenic mouse model of Gerstmann-Sträussler- Scheinker syndrome caused by the A117V mutation of PRNP. J. Neurosci. 29:10072-10080. doi:10.1523/JNEUROSCI.2542-09.2009
52. Yedidia, Y., L. Horonchik, S. Tzaban, A. Yanai, and A. Taraboulos. 2001. Proteasomes and ubiquitin are involved in the turnover of the wild-type prion protein. EMBO J. 20:5383-5391. doi:10.1093/emboj/20.19.5383